A long-term survivor keeping in a complete response without treatment after pemetrexed maintenance therapy for advanced non-squamous non-small cell lung cancer.

Makoto FurugenDaisuke ShibaharaTomo KiyunaWakaki KamiKazuya MiyagiShusaku HaranagaToru KubotaHirofumi MatsumotoNaoki YoshimiJiro Fujita

Published in: Clinical case reports (2020)

Pemetrexed has significant efficacy for some non-squamous non-small cell lung cancer cases, as demonstrated in the current case. For those patients, pemetrexed administration should be carefully considered.

Keyphrases

small cell lung cancer
advanced non small cell lung cancer
end stage renal disease
high grade
ejection fraction
newly diagnosed
chronic kidney disease
low grade
prognostic factors
peritoneal dialysis
patient reported